Luigia Rossi / Professoressa Ordinaria

vedi CV

PUBBLICAZIONI recenti (2018-2021)

1.      ROSSI L., PIERIGÈ F., BREGALDA A., MAGNANI M. (2021). Preclinical developments of enzyme-loaded red blood cells.  EXPERT OPINION ON DRUG DELIVERY, vol. 18(1), p. 43-54, doi: 10.1080/17425247.2020.1822320.

2.      ROSSI L., PIERIGE' F., ALIANO M.P., MAGNANI M. (2020). Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies. BIODRUGS, vol. 34 (3), p. 265-272, doi.org/10.1007/s40259-020-00415-0.

3.      ROSSI L., PIERIGÈ, F., AGOSTINI M., BIGINI N., TERMOPOLI V., CAI Y.Z., ZHENG F., ZHAN C-G, LANDRY D.W., MAGNANI M. (2020). Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells. FRONTIERS IN PHYSIOLOGY, vol. 11, ISSN: 1664-042X, doi: 10.3389/fphys.2020.573492.

4.      FRATERNALE, ALESSANDRA, ZARA, CAROLINA, PIERIGÈ, FRANCESCA, ROSSI, LUIGIA, LIGI, DANIELA, AMAGLIANI, GIULIA, MANNELLO, FERDINANDO, SMIETANA, MICHAËL, MAGNANI, MAURO, BRANDI, GIORGIO, SCHIAVANO, GIUDITTA FIORELLA (2020). Redox homeostasis as a target for new antimycobacterial agents. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, ISSN: 0924-8579, doi: 10.1016/j.ijantimicag.2020.106148.

5.      BIAGIOTTI, SARA, BIANCHI, MARZIA, ROSSI, LUIGIA, CHESSA, LUCIANA, MAGNANI, MAURO (2019). Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38. PLOS ONE, vol. 14, ISSN: 1932-6203, doi: 10.1371/journal.pone.0216668

6.      CAROLINA CONTER, ELISA OPPICI, MIRCO DINDO, LUIGIA ROSSI, MAURO MAGNANI, BARBARA CELLINI (2019). Biochemical properties and oxalate-degrading activity of oxalate decarboxilase from bacillus subtilis at neutral pH. IUBMB LIFE, vol. 71, p. 917-927, ISSN: 1521-6543, doi: 10.1002/iub.2027

7.      MACHOVER D., ROSSI L., HAMELIN J., DESTERKE C., GOLDSCHMIDT E., CHADEFAUX-VEKEMANS B., BONNARME P., BRIOZZO P., KOPE?NÝ D., PIERIGÈ F., MAGNANI M., MOLLICONE R., HAGHIGHI-RAD F., GASTON-MATHÉ Y., DAIROU J., BOUCHEIX C., SAFFROY R. (2019). Effects in cancer cells of the recombinant L-Methionine gamma-lyase from Brevibacterium aurantiacum. Encapsulation in human erythrocytes for sustained L-methionine elimination. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 369, p. 489-502, ISSN: 0022-3565, doi: 10.1124/jpet.119.256537.

8.      ROSSI, LUIGIA, FRATERNALE, ALESSANDRA, BIANCHI, MARZIA, MAGNANI, MAURO (2019). Red blood cell membrane processing for biomedical applications. FRONTIERS IN PHYSIOLOGY, VOL. 10, ISSN: 1664-042X, DOI: 10.3389/FPHYS.2019.01070

9.      PASCUCCI T., ROSSI L., COLAMARTINO M., GABUCCI C., CARDUCCI C., VALZANIA A., SASSO V., BIGINI N., PIERIGÈ F., VISCOMI M.T., VENTURA R., CABI S., MAGNANI M., PUGLISI-ALLEGRA S., LEUZZI V. (2018). A new therapy prevents intellectual disability in mouse with phenylketonuria. MOLECULAR GENETICS AND METABOLISM, vol. 124, p. 39-49, ISSN: 1096-7192, doi: 10.1016/j.ymgme.2018.03.009. Tiziana Pascucci and Luigia Rossi contributed equally to this study.

10.  SABATINO R., BATTISTELLI S., MAGNANI M., ROSSI L. (2018). Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes. DRUG DELIVERY AND TRANSLATIONAL RESEARCH, vol. 8, p. 1355-1364, ISSN: 2190-393X, doi: 10.1007/s13346-018-0560-2.

11.  MENOTTA, MICHELE, BIAGIOTTI, SARA, ORAZI, SARA, ROSSI, LUIGIA, CHESSA, LUCIANA, LEUZZI, VINCENZO, D'AGNANO, DANIELA, PLEBANI, ALESSANDRO, SORESINA, ANNAROSA, MAGNANI, MAURO (2018). In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia. MOLECULAR AND CELLULAR BIOCHEMISTRY, ISSN: 1573-4919, doi: 10.1007/s11010-017-3122-x